Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-19-041667
Filing Date
2019-08-26
Accepted
2019-08-26 16:16:55
Documents
6
Effectiveness Date
2019-08-26

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tv528283_s8.htm S-8 98537
2 EXHIBIT 5.1 tv528283_ex5-1.htm EX-5.1 9741
3 EXHIBIT 23.1 tv528283_ex23-1.htm EX-23.1 2615
4 GRAPHIC logo_001.jpg GRAPHIC 2852
5 GRAPHIC tv528283_ex23-1img01.jpg GRAPHIC 6440
6 GRAPHIC tv528283_ex23-1img02.jpg GRAPHIC 1712
  Complete submission text file 0001144204-19-041667.txt   127678
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233460 | Film No.: 191053115
SIC: 2834 Pharmaceutical Preparations